Anthem Biosciences Limited has informed the Exchange regarding Resignation of Mr K. Ramakrishnan as Other of the company w.e.f. March 31, 2026.
ANTHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.4 pts more than Nifty Midcap 150 and 2.2 pts more than its Pharmaceuticals & Biotechnology peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Mr. K. Ramakrishnan, General Counsel and Senior Management Personnel of Anthem Biosciences, has resigned effective March 31, 2026. He cited superannuation (retirement) as the reason for stepping down, following the company's recent listing. Mr. Ramakrishnan had been associated with the company since February 17, 2007, serving nearly 19 years, and was formally classified as Senior Management Personnel in November 2024. The resignation is part of a planned transition and his exit will not affect any director-level positions at the company.
This is a routine, planned retirement of a senior management member and is unlikely to materially affect operations or stock price. Investors may want to watch for the appointment of a new General Counsel to ensure continuity of legal and compliance functions.